REMS In The Time Of COVID-19: ACLU Sues FDA Over Abortion Pill Access
Executive Summary
Medical and advocacy groups claim FDA is requiring women to fill prescriptions for Mifeprex in person while waiving REMS requirement for in-person visits for other drugs.